Marco Witteveen

I help startups in medical products, services, and technology go from early-stage spark to global scale. As a senior executive and growth catalyst, I bring strategic clarity, commercialisation expertise, and the ability to rapidly adapt to market shifts. With a track record in business planning, product and market strategy, and global market entry, I’ve partnered […]

Austin Smith

Austin Smith is a GMC-registered physician and pharmaceutical consultant with over 15 years in oncology drug development, dually trained in medical oncology and pharmaceutical medicine. He serves as Chief Medical Officer at Oxcia AB and Head of Clinical Development at Ariceum Therapeutics, leading early-phase and first-in-human programmes across haematological malignancies, radioligand theranostics, and orphan disease. […]

Kamel Abou Hussein MD

I am a breast medical oncologist, clinical researcher, and academic physician specializing in breast cancer care and clinical trials. As Director of Breast Medical Oncology and Director of the Breast Cancer Clinical Trials Program at MD Anderson Cancer Center at Cooper, I lead efforts to advance innovative treatment strategies and improve outcomes for patients with […]

Stephen Floor, PhD

Stephen Floor is a subject-matter expert in RNA science and medicine and computational biology with over 15 years of experience spanning academic research and biotechnology. His expertise bridges molecular biology, RNA biology, and computational approaches to understanding gene expression and developing RNA-based therapeutics.nnHe earned his PhD from UCSF in 2011, where he has built deep […]

Jerome Schentag

I have more than 90 patents and patent applications, which may be reviewed and accessed at https://www,schentag.com/ Notable inventions include cholestosomes, an oral and intracellular targeting system for delivery of proteins, peptides and nucleotides. I have recently co-founded Synergy Therapeutics a cancer company that uses cholestosomes to activate p53 inside cancer cells and thus drive […]

Ross Dehmoobed

I am a software and medical device product development leader with nearly two decades of experience in regulated and safety-critical environments. My passion is solving complex problems at the intersection of technology and healthcare, where innovation must meet the highest standards of safety, quality, and compliance. I’ve built and led cross-disciplinary teams of engineers, developers, […]

Wayne Jensen

I’ve spent 30 years in medtech and biotech—from the bench to the production floor to the C-suite—bringing more than 25 products to market across FDA 510(k), CE/MDR, and TGA pathways. I’ve seen exceptional science fail, not because the innovation wasn’t strong, but because the operational, regulatory, and governance foundations weren’t in place to support commercialization. […]

Jeff Spitzner

I am a 12x founder of life sciences technology startups, having raised over $30 million across my portfolio, with both successful exits and ongoing ventures. My companies have spanned biotechnology, software, medical devices, cosmeceuticals, gene therapy, and a venture studio investment platform. My expertise lies in technology commercialization — bringing innovative products from concept to […]

Sanjay S. Patel, M.D., M.Sc.

I am the Clinical Chief of the Hematopathology Division, and a physician-scientist at Weill Cornell, where I combine my clinical and research skills to advance the understanding and diagnosis of hematological malignancies. I am actively involved in patient care through hematopathology diagnostics. For several years, I also directed the Multiparametric In Situ Imaging (MISI) Laboratory, […]